Datasea
Datasea's revenue fell 43.2% to $41 million in fiscal 2026. Its operating margin was −5.7%, up from −7.2% a year earlier. Free cash flow was $2 million. The diluted share count rose 45.9%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity.
What Datasea does
Datasea is a Chinese technology company with two lines of business. The larger one provides digital services to businesses in China: digital marketing, messaging and data-processing services, technical services, and newer AI agents, software that carries out business tasks such as marketing work on a customer's instructions. The second develops products built on sound and ultrasound technology, such as air-health, sleep-health and personal-care devices, and NeuroVibe, a biofeedback and brain-computer-interaction product for which the company completed FDA registration and device listing after the year ended.
Nearly all of its revenue still comes from the digital business. In the year to June 30, 2026, revenue fell to about $40.70 million from $71.62 million, which the company says reflects its choice to cut back low-margin, high-volume digital services. Of that, about $39.96 million came from the digital business and about $0.63 million from sound-based products. All of its revenue was earned in China.
The company began operating in China in 2015 and in April 2026 moved its legal home from Nevada to the British Virgin Islands. It runs much of its business through a variable interest entity, a Chinese company it controls by contract rather than by owning shares. It had 42 full-time employees as of June 30, 2026.
Its biggest risks, as it describes them
- It has recurring losses and little cash, and its auditor has expressed substantial doubt that it can keep operating.
- Its shift toward sound-based health products and AI agents is recent and may not bring in enough revenue.
- NeuroVibe and its other health products face medical-device rules that could delay or limit sales.
- It runs much of its business through contracts with a Chinese entity it doesn't own, an arrangement that is uncertain under Chinese law.
- Its shares could be removed from the Nasdaq if it fails to meet its minimum bid price rule.
Income statement
Datasea lost money in fiscal 2026: a net loss of $2 million.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY24 | FY25 | FY26 |
|---|---|---|---|
| Cash and short-term investments | 0 | 1 | 0 |
| Debt incl. finance leases | — | — | — |
| Net debt (negative means net cash) | — | — | — |
| Net debt to EBITDA | — | — | — |
| Debt to equity | — | — | — |
| Interest coverage | −591.0x | −134.9x | −23.9x |
| Current ratio | — | 0.8x | 0.4x |
| Quick ratio | — | 0.8x | 0.4x |
Cash flow
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY25 | FY26 |
|---|---|---|
| Piotroski F-score | — | — |
| Rule of 40 | 195.4% | −38.3% |
| Altman Z'' | −26.56 | −12.22 |
| Accruals ratio | — | −38.7% |
The nine F-score tests
| Test | FY25 | FY26 |
|---|---|---|
| Net income is positive | — | Fail |
| Cash from operations is positive | Fail | Pass |
| Return on assets rose | — | — |
| Cash from operations exceeds net income | Pass | Pass |
| Debt fell relative to assets | — | — |
| Current ratio rose | — | Fail |
| Share count didn't rise | Fail | Fail |
| Gross margin rose | Pass | Pass |
| Revenue rose relative to assets | — | — |
| F-score | — | — |
Compare
Put Datasea side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Datasea | FY26 | −43.2% | −5.7% | 4.8% | — | — | — | |
| AudioEye | FY25 | 14.5% | −4.5% | 11.7% | −12.3% | 4.7x | 3 | Compare |
| Datavault AI | FY25 | 1,361.8% | −83.1% | −61.4% | — | — | — | Compare |
| Marchex | FY25 | −5.6% | −12.6% | −3.2% | — | — | — | Compare |
| Rezolve Ai | FY25 | 2,224.2% | −185.6% | −135.1% | — | — | — | Compare |
3 years of figures
| Fiscal year | FY24 | FY25 | FY26 |
|---|---|---|---|
| Income statement | |||
| Revenue | 24 | 72 | 41 |
| Revenue growth | — | 198.7% | −43.2% |
| Gross profit | 0 | 2 | 4 |
| Research and development | 0 | 1 | 3 |
| Operating income | −12 | −5 | −2 |
| Net income | −11 | −5 | −2 |
| Diluted EPS (US$) | −4.38 | −0.77 | −0.23 |
| Diluted shares (millions) | 3 | 7 | 10 |
| Cash flow | |||
| Cash from operations | −6 | −2 | 2 |
| Capital expenditure | 0 | 0 | 0 |
| Free cash flow | −6 | −2 | 2 |
| Dividends paid | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 |
| Stock-based compensation | 7 | 2 | 2 |
| Balance sheet at fiscal year end | |||
| Cash and short-term investments | 0 | 1 | 0 |
| Debt incl. finance leases | — | — | — |
| Total assets | — | 7 | 15 |
| Total liabilities | — | 4 | 8 |
| Shareholders' equity | −0 | 3 | 7 |
| Margins and ratios | |||
| Gross margin | 2.0% | 3.4% | 10.2% |
| Operating margin | −50.6% | −7.2% | −5.7% |
| Net margin | −47.5% | −7.1% | −5.4% |
| Free cash flow margin | −26.7% | −3.3% | 4.8% |
| Rule of 40 (growth + FCF margin) | — | 195.4% | −38.3% |
| Return on capital | — | — | — |
| Return on equity | — | — | −42.8% |
| Return on assets | — | — | −20.3% |
| Net debt to EBITDA | — | — | — |